ValeurQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26TTMFrais de vente, généraux et administratifs158.85 M157.23 M159.39 M152.77 M155.81 M154.57 M622.54 MRecherche et développement22.36 M23.29 M21.87 M21.25 M21.09 M21.28 M85.48 MRésultat d'exploitation37.69 M12.89 M10.59 M13.72 M5.63 M13.58 M43.52 MTotal des produits hors exploitation-6.02 M-1.76 M1.82 M607 K-894 K-1.06 M471 KCharges d'intérêts, nettes des intérêts capitalisés34.24 M22.03 M20.55 M19.81 M30.95 M16.49 M87.8 MRésultat hors exploitation, hors charges d'intérêts-40.26 M-23.79 M-18.73 M-19.2 M-31.84 M-17.55 M-87.33 MRevenus/dépenses exceptionnels———————Résultat avant impôts-66.01 M-10.91 M33.68 M-2.51 M1.87 M-3.98 M29.06 MPart des actionnaires dans le résultat002.84 M-1.54 M-2.48 M-607 K-1.8 MImpôts32.05 M4.57 M1.18 M-658 K-2.65 M-34.71 M-36.85 MIntérêts ne donnant pas le contrôle / intérêts minoritaires———————Autres produits/charges après impôts—-557 K1.18 M-10.18 M—-2.99 M—Résultat net avant activités abandonnées-23.83 M-15.48 M35.34 M-3.4 M-15.73 M30.13 M46.34 MActivités abandonnées———————Résultat net-23.83 M-15.48 M35.34 M-3.4 M-15.73 M30.13 M46.34 MAjustement de dilution———————Dividendes privilégiés———————Résultat net dilué revenant aux actionnaires ordinaires-23.83 M-15.48 M35.34 M-3.4 M-15.73 M30.13 M46.34 MBénéfice par action de base (BPA de base)-0.97-0.631.43-0.14-0.631.221.88Bénéfice par action dilué (BPA dilué)-0.97-0.631.43-0.14-0.631.21.86Nombre moyen d'actions de base en circulation24.39 M24.54 M24.64 M24.69 M24.64 M24.76 M—Nombre d'actions en circulation après dilution24.39 M24.54 M24.71 M24.69 M24.9 M25.18 M—EBITDA475.73 M62.33 M60.25 M64.52 M376.88 M63.61 M565.26 MEBIT422.84 M12.89 M10.59 M13.72 M326.05 M13.58 M363.94 MCoût des ventes17.4 M394.59 M340.8 M336.11 M17.3 M324 M1.02 BAutres coûts des ventes———————Amortissements (flux de trésorerie)52.99 M49.45 M49.66 M50.8 M50.83 M50.03 M201.32 M
ICU Medical, Inc. - Common Stock
ICU Medical, Inc. is a medical technology company based in San Clemente, California. ICU Medical products are designed to prevent bloodstream infections and protect healthcare workers from exposure to infectious diseases or hazardous drugs. ICU Medical product line includes intravenous therapy (IV) products, pumps, needle-free vascular access devices, custom infusion sets, closed system hazardous drug handling devices and systems, sensor catheters, needle-free closed blood sampling systems, and hemodynamic monitoring systems.
ICU Medical products are designed to prevent bloodstream infections and protecting healthcare workers from exposure to infectious diseases or hazardous drugs. In addition, the company's IV medication compounding and delivery products are designed to improve medication and dosing accuracy and improve clinical workflows. In 2014 ICU Medical was named one of the 100 Most Trustworthy Companies in America by Forbes Magazine.